血液・血漿成分市場：製品、用途、エンドユーザー別-2024-2030年の世界予測

血液・血漿成分市場規模は2023年に438億4,000万米ドルと推計され、2024年には458億6,000万米ドルに達し、CAGR 5.57%で2030年には641億1,000万米ドルに達すると予測されます。

血液・血漿成分の世界市場

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは血液・血漿成分市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、血液・血漿成分市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-血液・血漿成分市場の市場規模および予測は？

2-血液・血漿成分市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-血液・血漿成分市場における技術動向と規制の枠組みは？

4-血液・血漿成分市場における主要ベンダーの市場シェアは？

5-血液・血漿成分市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 外科手術の数が増加し、安全な手術の必要性血液・血漿成分
    • 血液および血漿の寄付キャンペーンを奨励する政府の取り組み
    • 血液関連疾患と輸血医療の改善
  • 抑制要因
    • 血液および血漿製品の保管および有効期間に関する制限
  • 機会
    • 採血、処理、保管技術の進歩
    • 免疫グロブリン補充療法と凝固因子濃縮物の新たな導入
  • 課題
    • 血液および血漿製品の安全性と品質を確保するための厳格な規制
• 市場セグメンテーション分析
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 血液・血漿成分市場：製品別

• 血漿由来
• 輸血

第7章 血液・血漿成分市場：用途別

• 血液学
• 固形腫瘍の管理

第8章 血液・血漿成分市場：エンドユーザー別

• 診断研究所
• 病院
• 調査機関
• 専門クリニック

第9章 南北アメリカの血液・血漿成分市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の血液・血漿成分市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血液・血漿成分市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Abbott Laboratories
  • Alfa Laval Corporate AB
  • ANZCO Foods Limited
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Co.
  • Bio-Rad Laboratories, Inc.
  • BioChemed Services
  • bioMerieux SA
  • Biowest Company
  • CSL Behring LLC.
  • Grifols, S.A.
  • Immucor
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • MacoPharma
  • Meiji Holdings Co., Ltd.
  • Moregate Biotech
  • Octapharma AG
  • Pel-Freez, LLC
  • Rockland Immunochemicals, Inc. by BroadOak Capital Partners
  • Sanquin
  • TCS Biosciences Ltd.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. BLOOD & PLASMA COMPONENTS MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD & PLASMA COMPONENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BLOOD & PLASMA COMPONENTS MARKET DYNAMICS
• FIGURE 7. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 12. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 22. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. BLOOD & PLASMA COMPONENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA-DERIVED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SOLID TUMOR MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 144. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. BLOOD & PLASMA COMPONENTS MARKET LICENSE & PRICING

[194 Pages Report] The Blood & Plasma Components Market size was estimated at USD 43.84 billion in 2023 and expected to reach USD 45.86 billion in 2024, at a CAGR 5.57% to reach USD 64.11 billion by 2030.

Global Blood & Plasma Components Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood & Plasma Components Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood & Plasma Components Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood & Plasma Components Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Laval Corporate AB, ANZCO Foods Limited, Beckman Coulter, Inc., Becton, Dickinson & Co., Bio-Rad Laboratories, Inc., BioChemed Services, bioMerieux SA, Biowest Company, CSL Behring LLC., Grifols, S.A., Immucor, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., MacoPharma, Meiji Holdings Co., Ltd., Moregate Biotech, Octapharma AG, Pel-Freez, LLC, Rockland Immunochemicals, Inc. by BroadOak Capital Partners, Sanquin, and TCS Biosciences Ltd..

Market Segmentation & Coverage

This research report categorizes the Blood & Plasma Components Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Plasma-Derived
  • Transfusion
• Application
  • Hematology
  • Solid Tumor Management
• End User
  • Diagnostics Laboratories
  • Hospitals
  • Research Institutions
  • Specialty Clinics
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood & Plasma Components Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood & Plasma Components Market?

3. What are the technology trends and regulatory frameworks in the Blood & Plasma Components Market?

4. What is the market share of the leading vendors in the Blood & Plasma Components Market?

5. Which modes and strategic moves are suitable for entering the Blood & Plasma Components Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Blood & Plasma Components Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of surgical procedures and need for safe blood & plasma components
    • 5.1.1.2. Government initiatives encouraging blood & plasma donation campaigns
    • 5.1.1.3. Improvements in blood-related disorders and transfusion medicine
  • 5.1.2. Restraints
    • 5.1.2.1. Limitations associated with storage and shelf life of blood & plasma products
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in blood collection, processing, and storage technologies
    • 5.1.3.2. Emerging adoption of immunoglobulin replacement therapy and clotting factor concentrates
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations to ensure the safety & quality of blood & plasma products
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Blood & Plasma Components Market, by Product

• 6.1. Introduction
• 6.2. Plasma-Derived
• 6.3. Transfusion

7. Blood & Plasma Components Market, by Application

• 7.1. Introduction
• 7.2. Hematology
• 7.3. Solid Tumor Management

8. Blood & Plasma Components Market, by End User

• 8.1. Introduction
• 8.2. Diagnostics Laboratories
• 8.3. Hospitals
• 8.4. Research Institutions
• 8.5. Specialty Clinics

9. Americas Blood & Plasma Components Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Blood & Plasma Components Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Blood & Plasma Components Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Abbott Laboratories
  • 13.1.2. Alfa Laval Corporate AB
  • 13.1.3. ANZCO Foods Limited
  • 13.1.4. Beckman Coulter, Inc.
  • 13.1.5. Becton, Dickinson & Co.
  • 13.1.6. Bio-Rad Laboratories, Inc.
  • 13.1.7. BioChemed Services
  • 13.1.8. bioMerieux SA
  • 13.1.9. Biowest Company
  • 13.1.10. CSL Behring LLC.
  • 13.1.11. Grifols, S.A.
  • 13.1.12. Immucor
  • 13.1.13. Lake Immunogenics, Inc.
  • 13.1.14. LAMPIRE Biological Laboratories, Inc.
  • 13.1.15. MacoPharma
  • 13.1.16. Meiji Holdings Co., Ltd.
  • 13.1.17. Moregate Biotech
  • 13.1.18. Octapharma AG
  • 13.1.19. Pel-Freez, LLC
  • 13.1.20. Rockland Immunochemicals, Inc. by BroadOak Capital Partners
  • 13.1.21. Sanquin
  • 13.1.22. TCS Biosciences Ltd.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing